nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—HTR2C—obesity	0.0687	0.304	CbGaD
Mianserin—SLC6A4—obesity	0.0569	0.252	CbGaD
Mianserin—DRD2—obesity	0.0566	0.251	CbGaD
Mianserin—Diphenylpyraline—Benzphetamine—obesity	0.0554	0.348	CrCrCtD
Mianserin—Trimipramine—Benzphetamine—obesity	0.0542	0.34	CrCrCtD
Mianserin—Cyclizine—Benzphetamine—obesity	0.0497	0.312	CrCrCtD
Mianserin—HTR2A—obesity	0.0438	0.194	CbGaD
Mianserin—SLC6A3—Diethylpropion—obesity	0.0289	0.0666	CbGbCtD
Mianserin—HRH2—Cimetidine—obesity	0.0222	0.0511	CbGbCtD
Mianserin—SLC6A3—Sibutramine—obesity	0.0219	0.0505	CbGbCtD
Mianserin—SLC6A3—Phendimetrazine—obesity	0.0219	0.0505	CbGbCtD
Mianserin—SLC6A2—Diethylpropion—obesity	0.0212	0.0487	CbGbCtD
Mianserin—SLC6A4—Sibutramine—obesity	0.0192	0.0441	CbGbCtD
Mianserin—SLC6A3—Benzphetamine—obesity	0.0166	0.0382	CbGbCtD
Mianserin—SLC6A3—Phentermine—obesity	0.0166	0.0382	CbGbCtD
Mianserin—SLC6A2—Phendimetrazine—obesity	0.016	0.0369	CbGbCtD
Mianserin—SLC6A2—Sibutramine—obesity	0.016	0.0369	CbGbCtD
Mianserin—SLC6A3—Phenylpropanolamine—obesity	0.0158	0.0365	CbGbCtD
Mianserin—SLC6A4—Phentermine—obesity	0.0145	0.0335	CbGbCtD
Mianserin—SLC6A3—Bupropion—obesity	0.0141	0.0325	CbGbCtD
Mianserin—ADRA2C—Methamphetamine—obesity	0.0133	0.0306	CbGbCtD
Mianserin—SLC6A3—Methamphetamine—obesity	0.0133	0.0306	CbGbCtD
Mianserin—ADRA2B—Methamphetamine—obesity	0.0126	0.029	CbGbCtD
Mianserin—SLC6A2—Benzphetamine—obesity	0.0122	0.028	CbGbCtD
Mianserin—SLC6A2—Phentermine—obesity	0.0122	0.028	CbGbCtD
Mianserin—SLC6A4—Methamphetamine—obesity	0.0116	0.0267	CbGbCtD
Mianserin—SLC6A2—Phenylpropanolamine—obesity	0.0116	0.0267	CbGbCtD
Mianserin—ADRA2A—Benzphetamine—obesity	0.011	0.0252	CbGbCtD
Mianserin—ADRA2A—Phenylpropanolamine—obesity	0.0105	0.0241	CbGbCtD
Mianserin—SLC6A2—Bupropion—obesity	0.0103	0.0238	CbGbCtD
Mianserin—SLC6A2—Methamphetamine—obesity	0.00972	0.0224	CbGbCtD
Mianserin—ADRA2A—Methamphetamine—obesity	0.00876	0.0202	CbGbCtD
Mianserin—CYP2B6—Benzphetamine—obesity	0.00754	0.0174	CbGbCtD
Mianserin—CYP2B6—Bupropion—obesity	0.00642	0.0148	CbGbCtD
Mianserin—CYP1A2—Phentermine—obesity	0.00442	0.0102	CbGbCtD
Mianserin—CYP1A2—Phenylpropanolamine—obesity	0.00422	0.00972	CbGbCtD
Mianserin—CYP1A2—Bupropion—obesity	0.00376	0.00866	CbGbCtD
Mianserin—CYP2D6—Phentermine—obesity	0.00364	0.00839	CbGbCtD
Mianserin—CYP2D6—Bupropion—obesity	0.0031	0.00713	CbGbCtD
Mianserin—CYP3A4—Sibutramine—obesity	0.00306	0.00704	CbGbCtD
Mianserin—CYP2D6—Methamphetamine—obesity	0.00291	0.00671	CbGbCtD
Mianserin—CYP1A2—Cimetidine—obesity	0.00276	0.00636	CbGbCtD
Mianserin—CYP3A4—Benzphetamine—obesity	0.00232	0.00534	CbGbCtD
Mianserin—CYP2D6—Cimetidine—obesity	0.00227	0.00524	CbGbCtD
Mianserin—CYP3A4—Bupropion—obesity	0.00197	0.00454	CbGbCtD
Mianserin—SLC6A2—sympathetic nervous system—obesity	0.00164	0.067	CbGeAlD
Mianserin—CYP3A4—Orlistat—obesity	0.00161	0.0037	CbGbCtD
Mianserin—HTR7—sympathetic nervous system—obesity	0.00158	0.0645	CbGeAlD
Mianserin—HTR7—vagus nerve—obesity	0.00153	0.0625	CbGeAlD
Mianserin—CYP3A4—Cimetidine—obesity	0.00145	0.00333	CbGbCtD
Mianserin—SLC6A2—autonomic nervous system—obesity	0.0011	0.045	CbGeAlD
Mianserin—HTR7—autonomic nervous system—obesity	0.00106	0.0434	CbGeAlD
Mianserin—HTR2A—sympathetic nervous system—obesity	0.000985	0.0402	CbGeAlD
Mianserin—HTR2A—vagus nerve—obesity	0.000954	0.039	CbGeAlD
Mianserin—CYP3A4—Topiramate—obesity	0.000947	0.00218	CbGbCtD
Mianserin—HTR2A—autonomic nervous system—obesity	0.000662	0.0271	CbGeAlD
Mianserin—SLC6A3—hindbrain—obesity	0.000575	0.0235	CbGeAlD
Mianserin—SLC6A4—hindbrain—obesity	0.000527	0.0215	CbGeAlD
Mianserin—HTR1A—hindbrain—obesity	0.000468	0.0191	CbGeAlD
Mianserin—HTR7—hindbrain—obesity	0.000447	0.0183	CbGeAlD
Mianserin—DRD2—hindbrain—obesity	0.000423	0.0173	CbGeAlD
Mianserin—HRH2—cardiovascular system—obesity	0.000412	0.0168	CbGeAlD
Mianserin—Agranulocytosis—Cimetidine—obesity	0.000398	0.00606	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methamphetamine—obesity	0.000394	0.00601	CcSEcCtD
Mianserin—Tremor—Phenylpropanolamine—obesity	0.000394	0.006	CcSEcCtD
Mianserin—Tachycardia—Phendimetrazine—obesity	0.000392	0.00597	CcSEcCtD
Mianserin—Constipation—Methamphetamine—obesity	0.000391	0.00595	CcSEcCtD
Mianserin—Bradycardia—Cimetidine—obesity	0.000389	0.00593	CcSEcCtD
Mianserin—Agitation—Phenylpropanolamine—obesity	0.000386	0.00588	CcSEcCtD
Mianserin—Hepatitis—Cimetidine—obesity	0.000382	0.00582	CcSEcCtD
Mianserin—Gastrointestinal disorder—Benzphetamine—obesity	0.00038	0.00579	CcSEcCtD
Mianserin—Tremor—Phentermine—obesity	0.000377	0.00574	CcSEcCtD
Mianserin—Hepatic enzyme increased—Bupropion—obesity	0.000375	0.00571	CcSEcCtD
Mianserin—Agitation—Phentermine—obesity	0.00037	0.00563	CcSEcCtD
Mianserin—Hyperkinesia—Sibutramine—obesity	0.000355	0.0054	CcSEcCtD
Mianserin—SLC6A3—respiratory system—obesity	0.000351	0.0144	CbGeAlD
Mianserin—Hypertension—Phentermine—obesity	0.000347	0.00529	CcSEcCtD
Mianserin—Confusional state—Phenylpropanolamine—obesity	0.000346	0.00527	CcSEcCtD
Mianserin—Constipation—Phendimetrazine—obesity	0.000343	0.00523	CcSEcCtD
Mianserin—HRH2—digestive system—obesity	0.000342	0.014	CbGeAlD
Mianserin—Hepatic function abnormal—Sibutramine—obesity	0.000338	0.00515	CcSEcCtD
Mianserin—Dry mouth—Phentermine—obesity	0.000335	0.0051	CcSEcCtD
Mianserin—Bone marrow depression—Topiramate—obesity	0.000335	0.0051	CcSEcCtD
Mianserin—Tachycardia—Phenylpropanolamine—obesity	0.000335	0.0051	CcSEcCtD
Mianserin—Oedema—Phentermine—obesity	0.000328	0.005	CcSEcCtD
Mianserin—Tremor—Diethylpropion—obesity	0.000328	0.00499	CcSEcCtD
Mianserin—HRH2—adrenal gland—obesity	0.000326	0.0133	CbGeAlD
Mianserin—Nasal congestion—Sibutramine—obesity	0.000324	0.00494	CcSEcCtD
Mianserin—Suicidal ideation—Topiramate—obesity	0.000322	0.00491	CcSEcCtD
Mianserin—SLC6A4—respiratory system—obesity	0.000322	0.0132	CbGeAlD
Mianserin—Agitation—Diethylpropion—obesity	0.000322	0.0049	CcSEcCtD
Mianserin—Hypotension—Phenylpropanolamine—obesity	0.000321	0.00488	CcSEcCtD
Mianserin—Tachycardia—Phentermine—obesity	0.00032	0.00488	CcSEcCtD
Mianserin—Gynaecomastia—Bupropion—obesity	0.000317	0.00483	CcSEcCtD
Mianserin—Arthritis—Orlistat—obesity	0.000314	0.00478	CcSEcCtD
Mianserin—Leukopenia—Diethylpropion—obesity	0.000313	0.00477	CcSEcCtD
Mianserin—Hyperkinesia—Bupropion—obesity	0.000309	0.00471	CcSEcCtD
Mianserin—Agitation—Cimetidine—obesity	0.000306	0.00466	CcSEcCtD
Mianserin—Somnolence—Phenylpropanolamine—obesity	0.000305	0.00464	CcSEcCtD
Mianserin—Arthritis—Sibutramine—obesity	0.000304	0.00463	CcSEcCtD
Mianserin—Convulsion—Diethylpropion—obesity	0.000303	0.00462	CcSEcCtD
Mianserin—Dizziness—Methamphetamine—obesity	0.000302	0.0046	CcSEcCtD
Mianserin—Leukopenia—Cimetidine—obesity	0.000298	0.00454	CcSEcCtD
Mianserin—Myalgia—Diethylpropion—obesity	0.000298	0.00454	CcSEcCtD
Mianserin—Hepatic function abnormal—Bupropion—obesity	0.000295	0.00449	CcSEcCtD
Mianserin—Constipation—Phenylpropanolamine—obesity	0.000293	0.00447	CcSEcCtD
Mianserin—Dizziness—Benzphetamine—obesity	0.000291	0.00444	CcSEcCtD
Mianserin—Dry mouth—Diethylpropion—obesity	0.000291	0.00444	CcSEcCtD
Mianserin—Headache—Methamphetamine—obesity	0.000286	0.00436	CcSEcCtD
Mianserin—SLC6A2—respiratory system—obesity	0.000283	0.0116	CbGeAlD
Mianserin—Myalgia—Cimetidine—obesity	0.000283	0.00432	CcSEcCtD
Mianserin—Arthralgia—Cimetidine—obesity	0.000283	0.00432	CcSEcCtD
Mianserin—Gastrointestinal disorder—Phentermine—obesity	0.000283	0.00432	CcSEcCtD
Mianserin—Fatigue—Phentermine—obesity	0.000283	0.00431	CcSEcCtD
Mianserin—Nasal congestion—Bupropion—obesity	0.000283	0.00431	CcSEcCtD
Mianserin—Feeling abnormal—Phenylpropanolamine—obesity	0.000283	0.00431	CcSEcCtD
Mianserin—HRH2—endocrine gland—obesity	0.000282	0.0115	CbGeAlD
Mianserin—Cardiac arrest—Sibutramine—obesity	0.000281	0.00428	CcSEcCtD
Mianserin—Constipation—Phentermine—obesity	0.000281	0.00428	CcSEcCtD
Mianserin—HTR2A—hindbrain—obesity	0.000279	0.0114	CbGeAlD
Mianserin—Tachycardia—Diethylpropion—obesity	0.000279	0.00424	CcSEcCtD
Mianserin—Headache—Benzphetamine—obesity	0.000276	0.0042	CcSEcCtD
Mianserin—Breast disorder—Orlistat—obesity	0.000276	0.0042	CcSEcCtD
Mianserin—Confusional state—Cimetidine—obesity	0.000274	0.00417	CcSEcCtD
Mianserin—HTR7—respiratory system—obesity	0.000273	0.0112	CbGeAlD
Mianserin—HTR2B—adrenal cortex—obesity	0.000268	0.0109	CbGeAlD
Mianserin—Thrombocytopenia—Cimetidine—obesity	0.000266	0.00405	CcSEcCtD
Mianserin—Dizziness—Phendimetrazine—obesity	0.000266	0.00404	CcSEcCtD
Mianserin—Tachycardia—Cimetidine—obesity	0.000265	0.00404	CcSEcCtD
Mianserin—Arthritis—Bupropion—obesity	0.000265	0.00404	CcSEcCtD
Mianserin—Lethargy—Bupropion—obesity	0.000263	0.004	CcSEcCtD
Mianserin—HTR1D—cardiovascular system—obesity	0.000263	0.0107	CbGeAlD
Mianserin—Musculoskeletal discomfort—Diethylpropion—obesity	0.00026	0.00396	CcSEcCtD
Mianserin—DRD2—respiratory system—obesity	0.000258	0.0106	CbGeAlD
Mianserin—Diplopia—Bupropion—obesity	0.000257	0.00392	CcSEcCtD
Mianserin—HRH2—liver—obesity	0.000255	0.0104	CbGeAlD
Mianserin—CYP2D6—hindbrain—obesity	0.000254	0.0104	CbGeAlD
Mianserin—Somnolence—Diethylpropion—obesity	0.000254	0.00387	CcSEcCtD
Mianserin—Headache—Phendimetrazine—obesity	0.000252	0.00383	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Cimetidine—obesity	0.000248	0.00377	CcSEcCtD
Mianserin—Gastrointestinal disorder—Diethylpropion—obesity	0.000247	0.00375	CcSEcCtD
Mianserin—HTR2B—cardiovascular system—obesity	0.000244	0.00998	CbGeAlD
Mianserin—Constipation—Diethylpropion—obesity	0.000244	0.00372	CcSEcCtD
Mianserin—Somnolence—Cimetidine—obesity	0.000242	0.00368	CcSEcCtD
Mianserin—Hepatic enzyme increased—Topiramate—obesity	0.000239	0.00364	CcSEcCtD
Mianserin—Asthenia—Phentermine—obesity	0.000235	0.00359	CcSEcCtD
Mianserin—Feeling abnormal—Diethylpropion—obesity	0.000235	0.00358	CcSEcCtD
Mianserin—Erectile dysfunction—Sibutramine—obesity	0.000235	0.00358	CcSEcCtD
Mianserin—Fatigue—Cimetidine—obesity	0.000234	0.00357	CcSEcCtD
Mianserin—Breast disorder—Bupropion—obesity	0.000233	0.00354	CcSEcCtD
Mianserin—Constipation—Cimetidine—obesity	0.000232	0.00354	CcSEcCtD
Mianserin—Weight increased—Sibutramine—obesity	0.000232	0.00354	CcSEcCtD
Mianserin—Dizziness—Phenylpropanolamine—obesity	0.000227	0.00345	CcSEcCtD
Mianserin—Feeling abnormal—Cimetidine—obesity	0.000224	0.00341	CcSEcCtD
Mianserin—Hepatobiliary disease—Orlistat—obesity	0.000222	0.00339	CcSEcCtD
Mianserin—HTR1A—cardiovascular system—obesity	0.000219	0.00895	CbGeAlD
Mianserin—CYP1A2—respiratory system—obesity	0.000218	0.0089	CbGeAlD
Mianserin—Dizziness—Phentermine—obesity	0.000217	0.00331	CcSEcCtD
Mianserin—Rash—Phenylpropanolamine—obesity	0.000216	0.00329	CcSEcCtD
Mianserin—Dermatitis—Phenylpropanolamine—obesity	0.000216	0.00329	CcSEcCtD
Mianserin—HTR2B—adipose tissue—obesity	0.000216	0.0088	CbGeAlD
Mianserin—ADRA2A—islet of Langerhans—obesity	0.000212	0.00867	CbGeAlD
Mianserin—Pancytopenia—Bupropion—obesity	0.000211	0.00322	CcSEcCtD
Mianserin—Hepatitis—Orlistat—obesity	0.000211	0.00322	CcSEcCtD
Mianserin—ADRA2C—adrenal cortex—obesity	0.000211	0.00861	CbGeAlD
Mianserin—HTR7—cardiovascular system—obesity	0.000209	0.00855	CbGeAlD
Mianserin—CYP2B6—respiratory system—obesity	0.000209	0.00853	CbGeAlD
Mianserin—Bradycardia—Sibutramine—obesity	0.000208	0.00317	CcSEcCtD
Mianserin—Rash—Phentermine—obesity	0.000207	0.00315	CcSEcCtD
Mianserin—Dermatitis—Phentermine—obesity	0.000207	0.00315	CcSEcCtD
Mianserin—Headache—Phentermine—obesity	0.000206	0.00313	CcSEcCtD
Mianserin—Erectile dysfunction—Bupropion—obesity	0.000205	0.00312	CcSEcCtD
Mianserin—SLC6A4—digestive system—obesity	0.000205	0.00836	CbGeAlD
Mianserin—HRH1—respiratory system—obesity	0.000204	0.00833	CbGeAlD
Mianserin—HTR2B—digestive system—obesity	0.000203	0.00829	CbGeAlD
Mianserin—Weight increased—Bupropion—obesity	0.000203	0.00308	CcSEcCtD
Mianserin—Mirtazapine—HRH3—obesity	0.000198	0.0863	CrCbGaD
Mianserin—Hyperkinesia—Topiramate—obesity	0.000197	0.003	CcSEcCtD
Mianserin—Asthenia—Cimetidine—obesity	0.000195	0.00297	CcSEcCtD
Mianserin—Jaundice—Bupropion—obesity	0.000193	0.00295	CcSEcCtD
Mianserin—HTR2B—adrenal gland—obesity	0.000193	0.0079	CbGeAlD
Mianserin—Eye disorder—Sibutramine—obesity	0.000191	0.00291	CcSEcCtD
Mianserin—Tinnitus—Sibutramine—obesity	0.000191	0.0029	CcSEcCtD
Mianserin—Mediastinal disorder—Orlistat—obesity	0.00019	0.0029	CcSEcCtD
Mianserin—Dizziness—Diethylpropion—obesity	0.000189	0.00288	CcSEcCtD
Mianserin—Angiopathy—Sibutramine—obesity	0.000185	0.00282	CcSEcCtD
Mianserin—Mental disorder—Orlistat—obesity	0.000185	0.00282	CcSEcCtD
Mianserin—Nasal congestion—Topiramate—obesity	0.00018	0.00274	CcSEcCtD
Mianserin—Rash—Diethylpropion—obesity	0.00018	0.00274	CcSEcCtD
Mianserin—Dermatitis—Diethylpropion—obesity	0.00018	0.00274	CcSEcCtD
Mianserin—Dizziness—Cimetidine—obesity	0.00018	0.00274	CcSEcCtD
Mianserin—Headache—Diethylpropion—obesity	0.000179	0.00272	CcSEcCtD
Mianserin—Hepatitis—Bupropion—obesity	0.000178	0.00271	CcSEcCtD
Mianserin—CYP2B6—adrenal cortex—obesity	0.000175	0.00716	CbGeAlD
Mianserin—DRD2—pituitary gland—obesity	0.000175	0.00716	CbGeAlD
Mianserin—Connective tissue disorder—Bupropion—obesity	0.000175	0.00267	CcSEcCtD
Mianserin—HTR7—digestive system—obesity	0.000174	0.0071	CbGeAlD
Mianserin—HTR1A—adrenal gland—obesity	0.000173	0.00708	CbGeAlD
Mianserin—SLC6A2—adrenal gland—obesity	0.000172	0.00702	CbGeAlD
Mianserin—Rash—Cimetidine—obesity	0.000171	0.00261	CcSEcCtD
Mianserin—Dermatitis—Cimetidine—obesity	0.000171	0.00261	CcSEcCtD
Mianserin—HTR2A—respiratory system—obesity	0.00017	0.00696	CbGeAlD
Mianserin—ADRA2C—pituitary gland—obesity	0.00017	0.00696	CbGeAlD
Mianserin—Headache—Cimetidine—obesity	0.00017	0.00259	CcSEcCtD
Mianserin—ADRA2C—adipose tissue—obesity	0.00017	0.00693	CbGeAlD
Mianserin—SLC6A4—endocrine gland—obesity	0.000169	0.00691	CbGeAlD
Mianserin—Lethargy—Topiramate—obesity	0.000167	0.00255	CcSEcCtD
Mianserin—Tremor—Sibutramine—obesity	0.000167	0.00254	CcSEcCtD
Mianserin—Eye disorder—Bupropion—obesity	0.000166	0.00254	CcSEcCtD
Mianserin—Tinnitus—Bupropion—obesity	0.000166	0.00253	CcSEcCtD
Mianserin—HTR7—adrenal gland—obesity	0.000166	0.00676	CbGeAlD
Mianserin—Cardiac disorder—Bupropion—obesity	0.000165	0.00252	CcSEcCtD
Mianserin—Vertigo—Orlistat—obesity	0.000165	0.00252	CcSEcCtD
Mianserin—Anaemia—Sibutramine—obesity	0.000164	0.0025	CcSEcCtD
Mianserin—Diplopia—Topiramate—obesity	0.000164	0.0025	CcSEcCtD
Mianserin—Agitation—Sibutramine—obesity	0.000163	0.00249	CcSEcCtD
Mianserin—Angiopathy—Bupropion—obesity	0.000162	0.00246	CcSEcCtD
Mianserin—Mediastinal disorder—Bupropion—obesity	0.000161	0.00245	CcSEcCtD
Mianserin—CYP2B6—cardiovascular system—obesity	0.00016	0.00654	CbGeAlD
Mianserin—Vertigo—Sibutramine—obesity	0.00016	0.00243	CcSEcCtD
Mianserin—Syncope—Sibutramine—obesity	0.00016	0.00243	CcSEcCtD
Mianserin—Convulsion—Orlistat—obesity	0.000159	0.00243	CcSEcCtD
Mianserin—Leukopenia—Sibutramine—obesity	0.000159	0.00243	CcSEcCtD
Mianserin—Myalgia—Orlistat—obesity	0.000156	0.00238	CcSEcCtD
Mianserin—Loss of consciousness—Sibutramine—obesity	0.000156	0.00238	CcSEcCtD
Mianserin—Mental disorder—Bupropion—obesity	0.000156	0.00238	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000155	0.00237	CcSEcCtD
Mianserin—Amitriptyline—NTRK2—obesity	0.000155	0.0677	CrCbGaD
Mianserin—Convulsion—Sibutramine—obesity	0.000154	0.00235	CcSEcCtD
Mianserin—Hypertension—Sibutramine—obesity	0.000154	0.00234	CcSEcCtD
Mianserin—Dry mouth—Orlistat—obesity	0.000153	0.00233	CcSEcCtD
Mianserin—ADRA2C—adrenal gland—obesity	0.000152	0.00622	CbGeAlD
Mianserin—Arthralgia—Sibutramine—obesity	0.000151	0.00231	CcSEcCtD
Mianserin—Myalgia—Sibutramine—obesity	0.000151	0.00231	CcSEcCtD
Mianserin—HTR1A—endocrine gland—obesity	0.00015	0.00614	CbGeAlD
Mianserin—Oedema—Orlistat—obesity	0.00015	0.00228	CcSEcCtD
Mianserin—SLC6A2—endocrine gland—obesity	0.000149	0.00608	CbGeAlD
Mianserin—Breast disorder—Topiramate—obesity	0.000148	0.00226	CcSEcCtD
Mianserin—Dry mouth—Sibutramine—obesity	0.000148	0.00226	CcSEcCtD
Mianserin—Nervous system disorder—Orlistat—obesity	0.000147	0.00224	CcSEcCtD
Mianserin—Confusional state—Sibutramine—obesity	0.000146	0.00223	CcSEcCtD
Mianserin—Skin disorder—Orlistat—obesity	0.000146	0.00222	CcSEcCtD
Mianserin—Tremor—Bupropion—obesity	0.000145	0.00221	CcSEcCtD
Mianserin—Oedema—Sibutramine—obesity	0.000145	0.00221	CcSEcCtD
Mianserin—HTR7—endocrine gland—obesity	0.000144	0.00586	CbGeAlD
Mianserin—Anaemia—Bupropion—obesity	0.000143	0.00218	CcSEcCtD
Mianserin—Shock—Sibutramine—obesity	0.000143	0.00218	CcSEcCtD
Mianserin—Agitation—Bupropion—obesity	0.000142	0.00217	CcSEcCtD
Mianserin—Thrombocytopenia—Sibutramine—obesity	0.000142	0.00216	CcSEcCtD
Mianserin—Tachycardia—Sibutramine—obesity	0.000142	0.00216	CcSEcCtD
Mianserin—Skin disorder—Sibutramine—obesity	0.000141	0.00215	CcSEcCtD
Mianserin—Vertigo—Bupropion—obesity	0.000139	0.00212	CcSEcCtD
Mianserin—Syncope—Bupropion—obesity	0.000139	0.00212	CcSEcCtD
Mianserin—Leukopenia—Bupropion—obesity	0.000139	0.00211	CcSEcCtD
Mianserin—CYP1A2—digestive system—obesity	0.000139	0.00566	CbGeAlD
Mianserin—HRH1—adipose tissue—obesity	0.000138	0.00563	CbGeAlD
Mianserin—Musculoskeletal discomfort—Orlistat—obesity	0.000137	0.00208	CcSEcCtD
Mianserin—Loss of consciousness—Bupropion—obesity	0.000136	0.00208	CcSEcCtD
Mianserin—ADRA2A—pituitary gland—obesity	0.000136	0.00555	CbGeAlD
Mianserin—DRD2—endocrine gland—obesity	0.000136	0.00554	CbGeAlD
Mianserin—Hypotension—Sibutramine—obesity	0.000136	0.00207	CcSEcCtD
Mianserin—ADRA2A—adipose tissue—obesity	0.000135	0.00553	CbGeAlD
Mianserin—Paraesthesia—Orlistat—obesity	0.000135	0.00205	CcSEcCtD
Mianserin—Pancytopenia—Topiramate—obesity	0.000135	0.00205	CcSEcCtD
Mianserin—Convulsion—Bupropion—obesity	0.000134	0.00205	CcSEcCtD
Mianserin—Hypertension—Bupropion—obesity	0.000134	0.00204	CcSEcCtD
Mianserin—CYP2B6—digestive system—obesity	0.000133	0.00543	CbGeAlD
Mianserin—Neutropenia—Topiramate—obesity	0.000133	0.00202	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Sibutramine—obesity	0.000132	0.00201	CcSEcCtD
Mianserin—Myalgia—Bupropion—obesity	0.000132	0.00201	CcSEcCtD
Mianserin—Arthralgia—Bupropion—obesity	0.000132	0.00201	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000131	0.002	CcSEcCtD
Mianserin—Erectile dysfunction—Topiramate—obesity	0.000131	0.00199	CcSEcCtD
Mianserin—HTR2A—cardiovascular system—obesity	0.000131	0.00533	CbGeAlD
Mianserin—Paraesthesia—Sibutramine—obesity	0.00013	0.00199	CcSEcCtD
Mianserin—HRH1—digestive system—obesity	0.00013	0.0053	CbGeAlD
Mianserin—Gastrointestinal disorder—Orlistat—obesity	0.000129	0.00197	CcSEcCtD
Mianserin—HTR7—liver—obesity	0.000129	0.00529	CbGeAlD
Mianserin—Fatigue—Orlistat—obesity	0.000129	0.00197	CcSEcCtD
Mianserin—Dry mouth—Bupropion—obesity	0.000129	0.00197	CcSEcCtD
Mianserin—Somnolence—Sibutramine—obesity	0.000129	0.00197	CcSEcCtD
Mianserin—Weight increased—Topiramate—obesity	0.000129	0.00197	CcSEcCtD
Mianserin—Confusional state—Bupropion—obesity	0.000128	0.00194	CcSEcCtD
Mianserin—CYP2B6—adrenal gland—obesity	0.000127	0.00517	CbGeAlD
Mianserin—Oedema—Bupropion—obesity	0.000127	0.00193	CcSEcCtD
Mianserin—Gastrointestinal disorder—Sibutramine—obesity	0.000125	0.00191	CcSEcCtD
Mianserin—Shock—Bupropion—obesity	0.000125	0.0019	CcSEcCtD
Mianserin—Constipation—Sibutramine—obesity	0.000124	0.00189	CcSEcCtD
Mianserin—Nervous system disorder—Bupropion—obesity	0.000124	0.00189	CcSEcCtD
Mianserin—Thrombocytopenia—Bupropion—obesity	0.000124	0.00189	CcSEcCtD
Mianserin—Feeling abnormal—Orlistat—obesity	0.000124	0.00188	CcSEcCtD
Mianserin—HRH1—adrenal gland—obesity	0.000124	0.00505	CbGeAlD
Mianserin—Tachycardia—Bupropion—obesity	0.000124	0.00188	CcSEcCtD
Mianserin—Skin disorder—Bupropion—obesity	0.000123	0.00187	CcSEcCtD
Mianserin—ADRA2A—adrenal gland—obesity	0.000121	0.00496	CbGeAlD
Mianserin—Feeling abnormal—Sibutramine—obesity	0.00012	0.00182	CcSEcCtD
Mianserin—ADRA2C—liver—obesity	0.000119	0.00486	CbGeAlD
Mianserin—Hypotension—Bupropion—obesity	0.000118	0.0018	CcSEcCtD
Mianserin—Agranulocytosis—Topiramate—obesity	0.000118	0.0018	CcSEcCtD
Mianserin—HTR2A—pituitary gland—obesity	0.000116	0.00472	CbGeAlD
Mianserin—Bradycardia—Topiramate—obesity	0.000116	0.00176	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Bupropion—obesity	0.000115	0.00176	CcSEcCtD
Mianserin—CYP1A2—endocrine gland—obesity	0.000114	0.00468	CbGeAlD
Mianserin—Paraesthesia—Bupropion—obesity	0.000114	0.00173	CcSEcCtD
Mianserin—Hepatitis—Topiramate—obesity	0.000113	0.00173	CcSEcCtD
Mianserin—Somnolence—Bupropion—obesity	0.000113	0.00171	CcSEcCtD
Mianserin—Connective tissue disorder—Topiramate—obesity	0.000112	0.0017	CcSEcCtD
Mianserin—CYP2B6—endocrine gland—obesity	0.00011	0.00448	CbGeAlD
Mianserin—Gastrointestinal disorder—Bupropion—obesity	0.000109	0.00166	CcSEcCtD
Mianserin—Fatigue—Bupropion—obesity	0.000109	0.00166	CcSEcCtD
Mianserin—HTR2A—digestive system—obesity	0.000108	0.00443	CbGeAlD
Mianserin—Constipation—Bupropion—obesity	0.000108	0.00165	CcSEcCtD
Mianserin—Asthenia—Orlistat—obesity	0.000108	0.00164	CcSEcCtD
Mianserin—HRH1—endocrine gland—obesity	0.000107	0.00438	CbGeAlD
Mianserin—Pruritus—Orlistat—obesity	0.000106	0.00162	CcSEcCtD
Mianserin—Eye disorder—Topiramate—obesity	0.000106	0.00162	CcSEcCtD
Mianserin—Tinnitus—Topiramate—obesity	0.000106	0.00161	CcSEcCtD
Mianserin—Cardiac disorder—Topiramate—obesity	0.000105	0.0016	CcSEcCtD
Mianserin—ADRA2A—endocrine gland—obesity	0.000105	0.0043	CbGeAlD
Mianserin—Feeling abnormal—Bupropion—obesity	0.000104	0.00159	CcSEcCtD
Mianserin—Asthenia—Sibutramine—obesity	0.000104	0.00159	CcSEcCtD
Mianserin—HTR2A—adrenal gland—obesity	0.000103	0.00422	CbGeAlD
Mianserin—CYP1A2—liver—obesity	0.000103	0.00422	CbGeAlD
Mianserin—Angiopathy—Topiramate—obesity	0.000103	0.00157	CcSEcCtD
Mianserin—Pruritus—Sibutramine—obesity	0.000103	0.00156	CcSEcCtD
Mianserin—Mediastinal disorder—Topiramate—obesity	0.000102	0.00156	CcSEcCtD
Mianserin—CYP3A4—digestive system—obesity	0.0001	0.0041	CbGeAlD
Mianserin—Mental disorder—Topiramate—obesity	9.94e-05	0.00151	CcSEcCtD
Mianserin—Dizziness—Orlistat—obesity	9.92e-05	0.00151	CcSEcCtD
Mianserin—CYP2B6—liver—obesity	9.89e-05	0.00404	CbGeAlD
Mianserin—CYP2D6—digestive system—obesity	9.87e-05	0.00403	CbGeAlD
Mianserin—Mirtazapine—DRD4—obesity	9.8e-05	0.0427	CrCbGaD
Mianserin—Dizziness—Sibutramine—obesity	9.6e-05	0.00146	CcSEcCtD
Mianserin—Rash—Orlistat—obesity	9.46e-05	0.00144	CcSEcCtD
Mianserin—Dermatitis—Orlistat—obesity	9.45e-05	0.00144	CcSEcCtD
Mianserin—Headache—Orlistat—obesity	9.4e-05	0.00143	CcSEcCtD
Mianserin—Tremor—Topiramate—obesity	9.26e-05	0.00141	CcSEcCtD
Mianserin—Rash—Sibutramine—obesity	9.15e-05	0.00139	CcSEcCtD
Mianserin—Dermatitis—Sibutramine—obesity	9.14e-05	0.00139	CcSEcCtD
Mianserin—Anaemia—Topiramate—obesity	9.13e-05	0.00139	CcSEcCtD
Mianserin—Headache—Sibutramine—obesity	9.09e-05	0.00139	CcSEcCtD
Mianserin—Metixene—HTR2C—obesity	9.08e-05	0.0396	CrCbGaD
Mianserin—Asthenia—Bupropion—obesity	9.08e-05	0.00138	CcSEcCtD
Mianserin—Agitation—Topiramate—obesity	9.08e-05	0.00138	CcSEcCtD
Mianserin—Pruritus—Bupropion—obesity	8.95e-05	0.00136	CcSEcCtD
Mianserin—HTR2A—endocrine gland—obesity	8.95e-05	0.00366	CbGeAlD
Mianserin—Vertigo—Topiramate—obesity	8.88e-05	0.00135	CcSEcCtD
Mianserin—Syncope—Topiramate—obesity	8.86e-05	0.00135	CcSEcCtD
Mianserin—Leukopenia—Topiramate—obesity	8.84e-05	0.00135	CcSEcCtD
Mianserin—Loss of consciousness—Topiramate—obesity	8.68e-05	0.00132	CcSEcCtD
Mianserin—Convulsion—Topiramate—obesity	8.56e-05	0.0013	CcSEcCtD
Mianserin—Hypertension—Topiramate—obesity	8.53e-05	0.0013	CcSEcCtD
Mianserin—Arthralgia—Topiramate—obesity	8.41e-05	0.00128	CcSEcCtD
Mianserin—Myalgia—Topiramate—obesity	8.41e-05	0.00128	CcSEcCtD
Mianserin—Dizziness—Bupropion—obesity	8.37e-05	0.00127	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.35e-05	0.00127	CcSEcCtD
Mianserin—CYP3A4—endocrine gland—obesity	8.29e-05	0.00339	CbGeAlD
Mianserin—Dry mouth—Topiramate—obesity	8.23e-05	0.00125	CcSEcCtD
Mianserin—CYP2D6—endocrine gland—obesity	8.15e-05	0.00333	CbGeAlD
Mianserin—Confusional state—Topiramate—obesity	8.13e-05	0.00124	CcSEcCtD
Mianserin—HTR2A—liver—obesity	8.07e-05	0.0033	CbGeAlD
Mianserin—Oedema—Topiramate—obesity	8.06e-05	0.00123	CcSEcCtD
Mianserin—Rash—Bupropion—obesity	7.98e-05	0.00122	CcSEcCtD
Mianserin—Dermatitis—Bupropion—obesity	7.97e-05	0.00121	CcSEcCtD
Mianserin—Shock—Topiramate—obesity	7.93e-05	0.00121	CcSEcCtD
Mianserin—Headache—Bupropion—obesity	7.93e-05	0.00121	CcSEcCtD
Mianserin—Nervous system disorder—Topiramate—obesity	7.91e-05	0.0012	CcSEcCtD
Mianserin—Thrombocytopenia—Topiramate—obesity	7.89e-05	0.0012	CcSEcCtD
Mianserin—Tachycardia—Topiramate—obesity	7.87e-05	0.0012	CcSEcCtD
Mianserin—Skin disorder—Topiramate—obesity	7.83e-05	0.00119	CcSEcCtD
Mianserin—Mirtazapine—ADRB1—obesity	7.7e-05	0.0336	CrCbGaD
Mianserin—Hypotension—Topiramate—obesity	7.53e-05	0.00115	CcSEcCtD
Mianserin—CYP3A4—liver—obesity	7.47e-05	0.00305	CbGeAlD
Mianserin—CYP2D6—liver—obesity	7.35e-05	0.003	CbGeAlD
Mianserin—Musculoskeletal discomfort—Topiramate—obesity	7.35e-05	0.00112	CcSEcCtD
Mianserin—Paraesthesia—Topiramate—obesity	7.24e-05	0.0011	CcSEcCtD
Mianserin—Somnolence—Topiramate—obesity	7.17e-05	0.00109	CcSEcCtD
Mianserin—Mirtazapine—HTR2C—obesity	7.1e-05	0.0309	CrCbGaD
Mianserin—Gastrointestinal disorder—Topiramate—obesity	6.96e-05	0.00106	CcSEcCtD
Mianserin—Fatigue—Topiramate—obesity	6.95e-05	0.00106	CcSEcCtD
Mianserin—Constipation—Topiramate—obesity	6.89e-05	0.00105	CcSEcCtD
Mianserin—Cyproheptadine—HTR2C—obesity	6.88e-05	0.03	CrCbGaD
Mianserin—Feeling abnormal—Topiramate—obesity	6.64e-05	0.00101	CcSEcCtD
Mianserin—Mirtazapine—ADRB2—obesity	6.48e-05	0.0282	CrCbGaD
Mianserin—Mirtazapine—SLC6A4—obesity	5.88e-05	0.0256	CrCbGaD
Mianserin—Mirtazapine—DRD2—obesity	5.85e-05	0.0255	CrCbGaD
Mianserin—Asthenia—Topiramate—obesity	5.78e-05	0.000881	CcSEcCtD
Mianserin—Prochlorperazine—HTR2C—obesity	5.77e-05	0.0251	CrCbGaD
Mianserin—Epinastine—HTR2A—obesity	5.74e-05	0.025	CrCbGaD
Mianserin—Pruritus—Topiramate—obesity	5.7e-05	0.000869	CcSEcCtD
Mianserin—Cyproheptadine—DRD2—obesity	5.67e-05	0.0247	CrCbGaD
Mianserin—Desipramine—SLC22A1—obesity	5.49e-05	0.0239	CrCbGaD
Mianserin—Dizziness—Topiramate—obesity	5.33e-05	0.000812	CcSEcCtD
Mianserin—Rash—Topiramate—obesity	5.08e-05	0.000774	CcSEcCtD
Mianserin—Dermatitis—Topiramate—obesity	5.08e-05	0.000774	CcSEcCtD
Mianserin—Headache—Topiramate—obesity	5.05e-05	0.000769	CcSEcCtD
Mianserin—Prochlorperazine—DRD2—obesity	4.75e-05	0.0207	CrCbGaD
Mianserin—Nortriptyline—HTR2C—obesity	4.66e-05	0.0203	CrCbGaD
Mianserin—Imipramine—SLC22A1—obesity	4.66e-05	0.0203	CrCbGaD
Mianserin—Mirtazapine—HTR2A—obesity	4.52e-05	0.0197	CrCbGaD
Mianserin—Trimipramine—HTR2C—obesity	4.39e-05	0.0191	CrCbGaD
Mianserin—Cyproheptadine—HTR2A—obesity	4.38e-05	0.0191	CrCbGaD
Mianserin—Desipramine—ADRB1—obesity	4.16e-05	0.0182	CrCbGaD
Mianserin—Amitriptyline—HTR1B—obesity	3.97e-05	0.0173	CrCbGaD
Mianserin—Nortriptyline—SLC6A4—obesity	3.86e-05	0.0168	CrCbGaD
Mianserin—Nortriptyline—DRD2—obesity	3.84e-05	0.0167	CrCbGaD
Mianserin—Desipramine—HTR2C—obesity	3.84e-05	0.0167	CrCbGaD
Mianserin—Nortriptyline—CYP2E1—obesity	3.7e-05	0.0161	CrCbGaD
Mianserin—Trimipramine—SLC6A4—obesity	3.64e-05	0.0159	CrCbGaD
Mianserin—Oxcarbazepine—ALB—obesity	3.62e-05	0.0158	CrCbGaD
Mianserin—Trimipramine—DRD2—obesity	3.62e-05	0.0158	CrCbGaD
Mianserin—Desipramine—ADRB2—obesity	3.5e-05	0.0153	CrCbGaD
Mianserin—Imipramine—HTR2C—obesity	3.25e-05	0.0142	CrCbGaD
Mianserin—Amitriptyline—HTR2C—obesity	3.23e-05	0.0141	CrCbGaD
Mianserin—Desipramine—SLC6A4—obesity	3.18e-05	0.0139	CrCbGaD
Mianserin—Desipramine—DRD2—obesity	3.16e-05	0.0138	CrCbGaD
Mianserin—Desipramine—CYP2E1—obesity	3.04e-05	0.0133	CrCbGaD
Mianserin—Nortriptyline—HTR2A—obesity	2.97e-05	0.0129	CrCbGaD
Mianserin—Trimipramine—HTR2A—obesity	2.79e-05	0.0122	CrCbGaD
Mianserin—Imipramine—SLC6A4—obesity	2.7e-05	0.0118	CrCbGaD
Mianserin—Imipramine—DRD2—obesity	2.68e-05	0.0117	CrCbGaD
Mianserin—Amitriptyline—SLC6A4—obesity	2.68e-05	0.0117	CrCbGaD
Mianserin—Amitriptyline—DRD2—obesity	2.67e-05	0.0116	CrCbGaD
Mianserin—Imipramine—CYP2E1—obesity	2.58e-05	0.0113	CrCbGaD
Mianserin—Amitriptyline—CYP2E1—obesity	2.57e-05	0.0112	CrCbGaD
Mianserin—Desipramine—HTR2A—obesity	2.44e-05	0.0107	CrCbGaD
Mianserin—Imipramine—HTR2A—obesity	2.07e-05	0.00904	CrCbGaD
Mianserin—Amitriptyline—HTR2A—obesity	2.06e-05	0.00898	CrCbGaD
Mianserin—Nortriptyline—ALB—obesity	2.03e-05	0.00885	CrCbGaD
Mianserin—Amitriptyline—ALB—obesity	1.41e-05	0.00614	CrCbGaD
Mianserin—DRD3—Signaling Pathways—MAPK8—obesity	6.68e-07	7.6e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MYC—obesity	6.67e-07	7.59e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TYK2—obesity	6.67e-07	7.59e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TGFB1—obesity	6.66e-07	7.58e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CB—obesity	6.66e-07	7.58e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MTOR—obesity	6.66e-07	7.58e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—obesity	6.66e-07	7.58e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TGFB1—obesity	6.66e-07	7.57e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—FASN—obesity	6.66e-07	7.57e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MYC—obesity	6.63e-07	7.54e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—BCHE—obesity	6.63e-07	7.54e-06	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—obesity	6.62e-07	7.53e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—RHOA—obesity	6.62e-07	7.53e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TGFB1—obesity	6.61e-07	7.52e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GNAS—obesity	6.59e-07	7.5e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL2—obesity	6.58e-07	7.48e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3R1—obesity	6.57e-07	7.48e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NOS3—obesity	6.57e-07	7.48e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TYK2—obesity	6.57e-07	7.47e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—STAT3—obesity	6.56e-07	7.47e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TYK2—obesity	6.55e-07	7.45e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—obesity	6.55e-07	7.45e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3R1—obesity	6.55e-07	7.45e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOS3—obesity	6.55e-07	7.45e-06	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—obesity	6.55e-07	7.45e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—obesity	6.52e-07	7.42e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—RHOA—obesity	6.51e-07	7.41e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—RHOA—obesity	6.5e-07	7.39e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CB—obesity	6.47e-07	7.36e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF1—obesity	6.47e-07	7.36e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT2—obesity	6.46e-07	7.35e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOB—obesity	6.46e-07	7.34e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3R1—obesity	6.44e-07	7.33e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOS3—obesity	6.44e-07	7.33e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3R1—obesity	6.43e-07	7.32e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOS3—obesity	6.43e-07	7.32e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARA—obesity	6.43e-07	7.31e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—obesity	6.41e-07	7.3e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP2E1—obesity	6.39e-07	7.28e-06	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—obesity	6.39e-07	7.27e-06	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—obesity	6.36e-07	7.24e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NQO1—obesity	6.32e-07	7.19e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—obesity	6.29e-07	7.16e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—obesity	6.26e-07	7.12e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—PIK3CA—obesity	6.24e-07	7.1e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AGT—obesity	6.22e-07	7.08e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CD—obesity	6.21e-07	7.06e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—obesity	6.2e-07	7.05e-06	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—obesity	6.19e-07	7.04e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—LPL—obesity	6.16e-07	7.01e-06	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	6.15e-07	7e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SERPINE1—obesity	6.14e-07	6.99e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—PIK3CA—obesity	6.14e-07	6.98e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—PIK3CA—obesity	6.13e-07	6.97e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—obesity	6.11e-07	6.95e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—obesity	6.1e-07	6.94e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MYC—obesity	6.1e-07	6.94e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—obesity	6.09e-07	6.93e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TGFB1—obesity	6.08e-07	6.92e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CB—obesity	6.07e-07	6.9e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC2A4—obesity	6.06e-07	6.9e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GCG—obesity	6.06e-07	6.9e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MTOR—obesity	6.05e-07	6.88e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CB—obesity	6.05e-07	6.88e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAV1—obesity	6.04e-07	6.88e-06	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—obesity	6.04e-07	6.87e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK8—obesity	6.03e-07	6.86e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOA1—obesity	6.03e-07	6.86e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GPX1—obesity	6.01e-07	6.84e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—obesity	6.01e-07	6.84e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—obesity	6.01e-07	6.84e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—obesity	5.98e-07	6.81e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYCS—obesity	5.98e-07	6.81e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TYK2—obesity	5.97e-07	6.8e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—obesity	5.95e-07	6.77e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CB—obesity	5.95e-07	6.77e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MTOR—obesity	5.95e-07	6.77e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MTOR—obesity	5.94e-07	6.75e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CB—obesity	5.94e-07	6.75e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RHOA—obesity	5.92e-07	6.74e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GGT1—obesity	5.87e-07	6.68e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GOT1—obesity	5.87e-07	6.68e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3R1—obesity	5.86e-07	6.67e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—obesity	5.86e-07	6.67e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CD36—obesity	5.86e-07	6.66e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK8—obesity	5.82e-07	6.62e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—obesity	5.8e-07	6.6e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—obesity	5.79e-07	6.59e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK8—obesity	5.79e-07	6.59e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NCOA1—obesity	5.78e-07	6.58e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—obesity	5.77e-07	6.57e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PIK3CA—obesity	5.75e-07	6.55e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—STK11—obesity	5.7e-07	6.49e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP19A1—obesity	5.7e-07	6.49e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—obesity	5.67e-07	6.46e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PIK3CA—obesity	5.67e-07	6.45e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PIK3CA—obesity	5.66e-07	6.45e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—obesity	5.66e-07	6.44e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK8—obesity	5.63e-07	6.41e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PIK3CA—obesity	5.63e-07	6.4e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—obesity	5.62e-07	6.39e-06	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—obesity	5.61e-07	6.39e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CA—obesity	5.58e-07	6.35e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—obesity	5.55e-07	6.31e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—obesity	5.52e-07	6.29e-06	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—obesity	5.52e-07	6.28e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—obesity	5.51e-07	6.27e-06	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—obesity	5.51e-07	6.27e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CG—obesity	5.5e-07	6.26e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARA—obesity	5.44e-07	6.19e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—obesity	5.44e-07	6.18e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—obesity	5.42e-07	6.17e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MTOR—obesity	5.41e-07	6.16e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CB—obesity	5.41e-07	6.16e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—obesity	5.32e-07	6.05e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—obesity	5.31e-07	6.04e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COMT—obesity	5.3e-07	6.03e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—obesity	5.29e-07	6.02e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AGT—obesity	5.27e-07	6e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—obesity	5.25e-07	5.98e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—POMC—obesity	5.24e-07	5.96e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARGC1A—obesity	5.22e-07	5.95e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GNB3—obesity	5.22e-07	5.95e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—INS—obesity	5.21e-07	5.93e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—obesity	5.2e-07	5.92e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CA—obesity	5.18e-07	5.89e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—obesity	5.17e-07	5.88e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—obesity	5.17e-07	5.88e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—obesity	5.16e-07	5.87e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—obesity	5.15e-07	5.86e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—obesity	5.12e-07	5.83e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAV1—obesity	5.12e-07	5.82e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK8—obesity	5.11e-07	5.81e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—obesity	5.11e-07	5.81e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOA1—obesity	5.11e-07	5.81e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—obesity	5.1e-07	5.8e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—obesity	5.1e-07	5.8e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GNAS—obesity	5.09e-07	5.79e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK8—obesity	5.03e-07	5.72e-06	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—obesity	5.02e-07	5.72e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—obesity	5.02e-07	5.71e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK8—obesity	5.02e-07	5.71e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—obesity	5.02e-07	5.71e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—obesity	5.01e-07	5.71e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—obesity	5e-07	5.69e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—obesity	4.98e-07	5.67e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOB—obesity	4.98e-07	5.67e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—obesity	4.95e-07	5.63e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—obesity	4.94e-07	5.63e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—obesity	4.93e-07	5.61e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—obesity	4.92e-07	5.6e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—obesity	4.91e-07	5.58e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.89e-07	5.56e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CA—obesity	4.86e-07	5.53e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CD—obesity	4.84e-07	5.51e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CA—obesity	4.82e-07	5.48e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—obesity	4.78e-07	5.44e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—obesity	4.78e-07	5.43e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—obesity	4.77e-07	5.43e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—LPL—obesity	4.76e-07	5.41e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—obesity	4.7e-07	5.35e-06	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—obesity	4.7e-07	5.35e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—obesity	4.67e-07	5.32e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CG—obesity	4.66e-07	5.31e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GPX1—obesity	4.64e-07	5.28e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—obesity	4.63e-07	5.27e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—obesity	4.63e-07	5.27e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—obesity	4.6e-07	5.23e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—obesity	4.6e-07	5.23e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—obesity	4.59e-07	5.22e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—obesity	4.58e-07	5.22e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK8—obesity	4.57e-07	5.21e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3R1—obesity	4.57e-07	5.2e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—obesity	4.57e-07	5.2e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—obesity	4.56e-07	5.19e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CD36—obesity	4.52e-07	5.14e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—obesity	4.5e-07	5.12e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—POMC—obesity	4.44e-07	5.05e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—INS—obesity	4.41e-07	5.02e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CA—obesity	4.35e-07	4.95e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—obesity	4.34e-07	4.94e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—obesity	4.33e-07	4.93e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—obesity	4.28e-07	4.87e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—obesity	4.27e-07	4.86e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—obesity	4.26e-07	4.85e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—obesity	4.26e-07	4.85e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—obesity	4.26e-07	4.85e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—obesity	4.25e-07	4.84e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—obesity	4.23e-07	4.81e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CB—obesity	4.22e-07	4.8e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARA—obesity	4.2e-07	4.78e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CA—obesity	4.2e-07	4.78e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—obesity	4.18e-07	4.76e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—obesity	4.18e-07	4.75e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CA—obesity	4.18e-07	4.75e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CD—obesity	4.1e-07	4.66e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AGT—obesity	4.07e-07	4.63e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CA—obesity	4.06e-07	4.62e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—obesity	4.05e-07	4.6e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—obesity	3.99e-07	4.54e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—obesity	3.97e-07	4.52e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAV1—obesity	3.95e-07	4.5e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CA—obesity	3.95e-07	4.49e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOA1—obesity	3.94e-07	4.48e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—obesity	3.93e-07	4.48e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—obesity	3.89e-07	4.42e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—obesity	3.88e-07	4.41e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3R1—obesity	3.87e-07	4.4e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—obesity	3.87e-07	4.4e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—obesity	3.85e-07	4.38e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—obesity	3.72e-07	4.23e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CA—obesity	3.7e-07	4.21e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—obesity	3.7e-07	4.21e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CA—obesity	3.69e-07	4.19e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CA—obesity	3.63e-07	4.13e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CA—obesity	3.62e-07	4.12e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CG—obesity	3.6e-07	4.09e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—obesity	3.6e-07	4.09e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CB—obesity	3.57e-07	4.07e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—obesity	3.55e-07	4.04e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—obesity	3.54e-07	4.03e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—obesity	3.47e-07	3.95e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—obesity	3.43e-07	3.9e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—POMC—obesity	3.43e-07	3.9e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—obesity	3.41e-07	3.88e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—INS—obesity	3.41e-07	3.88e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—obesity	3.32e-07	3.78e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CA—obesity	3.3e-07	3.75e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—obesity	3.26e-07	3.71e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—obesity	3.22e-07	3.67e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—obesity	3.21e-07	3.65e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—obesity	3.2e-07	3.65e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CD—obesity	3.16e-07	3.6e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—obesity	3.12e-07	3.55e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—obesity	3.02e-07	3.44e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—obesity	3.01e-07	3.43e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3R1—obesity	2.99e-07	3.4e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—obesity	2.99e-07	3.4e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—obesity	2.96e-07	3.37e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—obesity	2.96e-07	3.36e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—obesity	2.92e-07	3.32e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CB—obesity	2.76e-07	3.14e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—obesity	2.73e-07	3.11e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—obesity	2.7e-07	3.07e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CA—obesity	2.57e-07	2.93e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CA—obesity	2.18e-07	2.48e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—obesity	2.1e-07	2.39e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—obesity	1.78e-07	2.02e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CA—obesity	1.68e-07	1.91e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—obesity	1.37e-07	1.56e-06	CbGpPWpGaD
